Publications

Publications

Filter Results: (16) Arrow Down

Show Results For

Page 1 of 16 Results
  • Awards

Low-Cost RCT Competition

By: Michael W. Toffel
Winner (with Matthew Johnson and David I. Levine) of the 2014 Coalition for Evidence-Based Policy Grant Competition on the subject of “Demonstrating How Low-Cost Randomized Controlled Trials Can Drive Effective Social Spending.” View Details
  • 2017
  • Article

The Impact of Training Informal Healthcare Providers in India: A Randomized Controlled Trial

By: Jishnu Das, Abhijit Chowdhury, Reshmaan Hussam and Abhijit Banerjee
Health care providers without formal medical qualifications provide more than 70% of all primary care in rural India. Training these informal providers may be one way to improve the quality of care where few alternatives exist. We report on a randomized controlled... View Details
Keywords: Health Care; India; Business Training; RCT; Health Care and Treatment; Training; Performance Evaluation; Performance Improvement; India
Related
  • Article

Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study

By: Maryaline Catillon
Keywords: Biomedical Research; R＆D; Innovation; Technology; Drug Trials; RCT; Health; Healthcare; Health Care And Treatment; Health Care Policy; Innovation and Invention; Innovation Strategy; Research and Development; Technological Innovation; Health Industry; Pharmaceutical Industry
Related
  • March 2016 (Revised March 2022)
  • Teaching Note

Evive Health and Workplace Influenza Vaccinations

By: John Beshears
Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective messages that improve individuals' health... View Details
Keywords: Vaccination; Influenza; Flu Shot; Preventive Care; Health Care; Behavioral Economics; Choice Architecture; Nudge; Experimental Design; Randomized Controlled Trial; RCT; Causal Inference; Health Care and Treatment; Insurance; Health; Consumer Behavior; Health Testing and Trials; Communication Strategy; Insurance Industry; Health Industry
Related
  • March 2016
  • Case

Evive Health and Workplace Influenza Vaccinations

By: John Beshears
Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective messages that improve individuals' health... View Details
Keywords: Vaccination; Influenza; Flu Shot; Preventive Care; Health Care; Behavioral Economics; Choice Architecture; Nudge; Experimental Design; Randomized Controlled Trial; RCT; Causal Inference; Consumer Behavior; Health Care and Treatment; Health Testing and Trials; Communication Strategy; Health Industry
Related

    Incentives for Bad Science

    Randomized controlled trials (RCTs) inform medical practice, health care delivery, follow-on research, regulation, and health policy. Yet, many RCTs are inadequately randomized, blinded, and reported. To analyze scientists' and firms' incentives to meet clinical trial... View Details
    • 2024
    • Working Paper

    Do Information Frictions and Corruption Perceptions Kill Competition? A Field Experiment on Public Procurement in Uganda

    By: Emanuele Colonnelli, Francesco Loiacono, Edwin Muhumuza and Edoardo Teso
    We study whether information frictions and corruption perceptions deter firms from doing business with the government. We conduct two nationwide randomized controlled trials (RCTs) in collaboration with the national public procurement supervisory and anti-corruption... View Details
    Keywords: Knowledge Use and Leverage; Government and Politics; Crime and Corruption; Trust; Perception; Business and Government Relations
    Related
    • 26 Apr 2019
    • HBS Seminar

    Maryaline Catillon, Harvard University

    • September 2017 (Revised July 2023)
    • Case

    Adaptive Platform Trials: The Clinical Trial of the Future?

    By: Ariel D. Stern and Sarah Mehta
    In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
    Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
    Related
    • August 2022
    • Case

    Rocket Learning: Evidence in Action

    By: Brian Trelstad, Tomas Rosales and Malini Sen
    Founders of Rocket Learning, an India-based nonprofit which focused on early childhood education (ECE), received an invitation from MIT’s Abdul Latif Jameel Poverty Action Lab (JPAL), a development research organization, to test its intervention for ECE with a... View Details
    Keywords: Social Entrepreneurship; Early Childhood Education; Nonprofit Organizations; Literacy; Values and Beliefs; Social and Collaborative Networks; Education Industry; India; Asia
    Related

      Trends and Predictors of Biomedical Research Quality, 1990-2015

      This work leverages the strengths of expert human assessments of randomized controlled trials (RCTs) included in Cochrane reviews with data science techniques to build a comprehensive database on biomedical research quality. The data links the full-text and... View Details

      • October 2019
      • Article

      Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations

      By: Derek C. Angus, Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc J. M. Bonten, Mary Brophy, Christopher Butler, Timothy F. Cloughesy, Lennie P. G. Derde, Laura J. Esserman, Ryan Ferguson, Louis Fiore, Sarah C. Gaffey, J. Michael Gaziano, Kathy Giusti, Herman Goossens, Stephane Heritier, Bradley Hyman, Michael Krams, Kay Larholt, Lisa M. LaVange, Philip Lavori, Andrew W. Lo, Alexander J. London, Victoria Manax, Colin McArthur, Genevieve O’Neill, Giovanni Parmigiani, Jane Perlmutter, Elizabeth A. Petzold, Craig Ritchie, Kathryn M. Rowan, Christopher W. Seymour, Nathan I. Shapiro, Diane M. Simeone, Bradley Smith, Bradley Spellberg, Ariel Dora Stern, Lorenzo Trippa, Mark Trusheim, Kert Viele, Patrick Y. Wen and Janet Woodcock
      Researchers, clinicians, policymakers, and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to answer with traditional, free-standing, parallel-group randomized controlled trials (RCTs). Examples include... View Details
      Keywords: Adaptive Platform Trials; Health Testing and Trials
      Related
      • March 2020
      • Article

      A Revolution in Economics? It's Just Getting Started...

      By: Shawn A. Cole, William Pariente and Anja Sautmann
      We have each experienced thrills and pain while supporting the mission of the Abdul Latif Jameel Poverty Action Lab, which facilitated many of the experiments described in the 2019 Nobel Prize citation. J-PAL in many ways seeks to fulfill what Angrist and Pischke... View Details
      Keywords: Randomized Control Trials; Economics; Research; Innovation and Invention
      Related
      • Article

      Financial Incentives for Exercise Adherence in Adults: Systematic Review and Meta-analysis

      By: Marc S. Mitchell, Jack M. Goodman, David A. Alter, Leslie K. John, Paul I. Oh, Maureen T. Pakosh and Guy E. Faulkner
      Context Less than 5% of U.S. adults accumulate the required dose of exercise to maintain health. Behavioral economics has stimulated renewed interest in economic-based, population-level health interventions to address this issue. Despite widespread implementation of... View Details
      Keywords: Exercise; Health; Behavior; Motivation and Incentives
      Related
      • 26 Jul 2022
      • Blog Post

      Driving Change in Education-to-Employment

      a federally-sponsored RCT study show that Year Up’s impact on the earnings of graduates are among the largest of any workforce organization in the country. My role as Strategic Advisor to the Office of the CEO is focused on two projects:... View Details
      • 10 Oct 2017
      • First Look

      First Look at New Research and Ideas, October 10, 2017

      (RCT)—was limited in many ways. While statistically rigorous and still considered the “gold standard” in clinical research, traditional RCTs were time-consuming, costly, and limited to testing just one new drug at a time. Adaptive... View Details
      Keywords: Sean Silverthorne